This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Samuel R. Pesin, MD; Matthew A. Thomas, MD; Morton E. Smith, MD
St Louis, Mo

Arch Ophthalmol. 1993;111(6):731.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We appreciate the comments of Lightman et al regarding our clinical case report. As for the choice of antifungal treatment without concurrent intracameral therapy, we were not involved in the patient's initial treatment. In October 1989, he presented to an outside hospital with systemic signs of candidemia. At that time, according to the referring physician, the patient had diffuse conjunctival hyperemia, posterior synechiae, and anterior and posterior uveitis, giving a limited view of the retina. He was treated with intravenous amphotericin B and topical drops, and the candidemia resolved after 1 month of therapy.

When we evaluated the patient's condition in February 1990, his eye examination revealed clear conjunctiva, no evidence of anterior chamber or vitreous inflammatory cells, resolved synechiae, and a clear view of the fundus. Thus, while Lightman et al point out that intravenous amphotericin B may have poor ocular penetration, our case resembles numerous others . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?